Latest News & Updates

Breaking News

  • 12 minutes ago

  • Simantini Singh Deo

ARCpoint Board Reviews Strategic Recommendations After Interim CEO Peter Kendall Steps Down
Breaking News
argenx To Acquire Forte Biosciences In $2.2 Billion Deal To Expand Autoimmune Disease Pipeline

Simantini Singh Deo

Other trending news you may like to read

ARCpoint Board Reviews Strategic Recommendations After Interim CEO Peter Kendall Steps Down

ARCpoint Board reviews strategic recommendations after Interim CEO Peter Kendall steps down.

Simantini Singh Deo

Pharma Now

argenx To Acquire Forte Biosciences In $2.2 Billion Deal To Expand Autoimmune Disease Pipeline

argenx to acquire Forte Biosciences in a $2.2 billion deal to expand its autoimmune disease pipeline.

Simantini Singh Deo

Pharma Now

Ascentage Pharma CEO Dr. Dajun Yang Ranked Among Top Global Small Molecule Leaders In The Medicine Maker Power List 2026

Ascentage Pharma CEO Dajun Yang ranked among top global small molecule leaders in Power List 2026.

Simantini Singh Deo

Pharma Now

Idorsia Partners With Jamjoom Pharma To Bring QUVIVIQ Insomnia Treatment To Saudi Arabia And The Levant

Idorsia partners with Jamjoom Pharma to bring QUVIVIQ insomnia treatment to Saudi Arabia and the Levant.

Simantini Singh Deo

Pharma Now